tiprankstipranks
Relmada Therapeutics (RLMD)
NASDAQ:RLMD

Relmada Therapeutics (RLMD) Balance Sheet

264 Followers

Relmada Therapeutics Balance Sheet

Relmada Therapeutics's total assets for Q3 2023 were $109.15M, a decrease of -19.49% from the previous quarter. RLMD total liabilities were $8.42M for the fiscal quarter, a -16.59% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 22Dec 21Dec 20Jun 19Jun 18
Total Assets
$ 152.91M$ 223.33M$ 118.19M$ 10.22M$ 3.05M
Total Liabilities
$ 12.47M$ 15.06M$ 12.60M$ 2.61M$ 8.56M
Total Equity Gross Minority
$ 140.44M$ 208.26M$ 105.58M$ 7.61M$ -5.51M
Total Capitalization
$ 140.44M$ 208.26M$ 105.58M$ 7.61M$ -2.86M
Preferred Stock Equity
-----
Capital Lease Obligations
-----
Currency in USD

Relmada Therapeutics Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis